Ole Peter Kristiansen

    20002023

    Publikationer pr. år

    Personlig profil

    Expertise

    Ischaemic heart disease: diabetic heart disease; VTE disease 

    Primære forskningsområder

    Previous research: Genetics and immunology in Type 1 diabetes. DMSc in this subject 2005.  

    Non-commercial : Effects of liraglutide in patients with stable coronary disease - focus on both heart and metabolic parameters.

    Company-initated studies on VTE (Bayer AS) and diabetic medication in heart disease (Bayer, Novartis)  

    Aktuel forskning

    Currently I am involved in studies related to the metabolic (endocrine) effects and effect on heart function of liraglutide in patients with stable coronary disease.

    Commercial studies are related to long term treatment with rivaroxaban in patients with  VTE (Bayer AS), effects of an GLP-1 agonist in patients with stable coronary disease (GSK)

    Mulige interessekonflikter

    Not stockholder in any companies involved in production of medical products.

    Have performed company sponsored  studies for Bayer AS, Novartis, GSK.

    Fingeraftryk

    Dyk ned i forskningsemnerne, hvor Ole Peter Kristiansen er aktive. Disse emneetiketter kommer fra denne persons arbejder. Sammen danner de et unikt fingerprint.
    • 1 Lignende profiler

    Samarbejde og topforskningsområder i de sidste fem år

    Seneste eksterne samarbejde på lande-/områdeniveau. Dyk ned i detaljerne ved at klikke på prikkerne eller